ŠPINAROVÁ, Lenka, Jindřich ŠPINAR and Jiří VÍTOVEC. Studie SOLOIST-WHF (SOLOIST-WHF study). Remedia. Praha: Remedia s.r.o., 2021, vol. 31, No 2, p. 148-150. ISSN 0862-8947.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Studie SOLOIST-WHF
Name in Czech Studie SOLOIST-WHF
Name (in English) SOLOIST-WHF study
Authors ŠPINAROVÁ, Lenka, Jindřich ŠPINAR and Jiří VÍTOVEC.
Edition Remedia, Praha, Remedia s.r.o. 2021, 0862-8947.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords (in Czech) Diabetes mellitus;sotagliflozin;dekompensace srdečního selhání
Keywords in English Diabetes mellitus; sotaglifloyin; worsening of heart failure
Tags Reviewed
Changed by Changed by: prof. MUDr. Lenka Špinarová, Ph.D., FESC, učo 1051. Changed: 17/5/2021 14:44.
Abstract
Studie SOLOIST-WHF srovnala podávání sotagliflozinu oproti placebu diabetikům hospitalizovaným pro zhoršení srdečního selhání. Byl prokázán efekt na kombinovaný primární cíl: kardiovaskulární mortalita, hospitalizace a urgentní návštěva ambulance pro zhoršení srdečního selhání
Abstract (in English)
SOLOIST study compared the administration of sotagliflozin and placebo in patients with diabetes mellitus hospitalised for worsening of heart failure. The evaluation proved an effect on combined primary endpoint:cardiovascular mortality,hospitalization and urgent visit for worsening of heart failure.
PrintDisplayed: 29/7/2024 09:30